Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Archives of Neurology

• Publication date

  2007-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHNEUR.64.3.431PMID 17353389
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans

  2006cited by this paper
• Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B

  2005cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

  2004influential reference
• Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain

  2004cited by this paper
• Staging of brain pathology related to sporadic Parkinson's disease.

  2003cited by this paper
• Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-β ligand in transgenic mice

  2003cited by this paper
• The Binding of 2-(4′-Methylaminophenyl)Benzothiazole to Postmortem Brain Homogenates Is Dominated by the Amyloid Component

  2003cited by this paper
• Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease

  1999cited by this paper
• Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.

  1999cited by this paper
• Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease'

  1998cited by this paper
• Consensus Report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease"

  1998cited by this paper
• The Ronald and Nancy Reagan Research Institute of the Alzheimer’s Association

  1997cited by this paper
• Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data

  1996cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD).

  1995cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• Alzheimer's disease. The commonest form of amyloidosis.

  1983influential reference

• Modern biomarkers as key tools in the early diagnosis and monitoring of Alzheimer's disease progression

  2025cites this paper
• Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease

  2025cites this paper
• The AHA/ASA and DSM-V diagnostic criteria for vascular cognitive impairment identify cases with predominant vascular pathology

  2024cites this paper
• Bioactive Compounds of the Mediterranean Diet as Nutritional Support to Fight Neurodegenerative Disease

  2023cites this paper
• Traumatic brain injury and Alzheimer’s Disease biomarkers: A systematic review of findings from amyloid and tau positron emission tomography (PET)

  2023cites this paper
• Update Amyloid-Bildgebung in der Diagnostik der Neurodegeneration

  2022cites this paper
• Identifying Mild Alzheimer's Disease With First 30-Min 11C-PiB PET Scan

  2022cites this paper
• Cerebral Amyloid Angiopathy

  2021cites this paper
• Illuminating Protein Phase Separation: Reviewing Aggregation-Induced Emission, Fluorescent Molecular Rotor and Solvatochromic Fluorophore based Probes.

  2021cites this paper
• When Does Alzheimer's Disease Really Start? The Role of Biomarkers.

  2021cites this paper
• PET and SPECT Imaging of Neurodegenerative Diseases

  2021cites this paper
• Postmortem Neocortical 3H-PiB Binding and Levels of Unmodified and Pyroglutamate Aβ in Down Syndrome and Sporadic Alzheimer’s Disease

  2021cites this paper
• Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-β PET Signal

  2021cites this paper
• Psychosocial Interventions in Dementia

  2020cites this paper
• Epidemiology and Mental Health in Old Age

  2020cites this paper
• Contributions of PET and MRI imaging in the evaluation of CNS drugs in human neurodegenerative diseases.

  2020cites this paper
• Controlling the Confusion

  2020cites this paper
• Deprivation of Liberty

  2020cites this paper
• Neuroimaging in dementias

  2020cites this paper
• Mini-Mental State Examination for the Detection and Prediction of Dementia in People with and without Mild Cognitive Impairment

  2020cites this paper
• Mental Health in Parkinson’s Disease

  2020cites this paper
• Drug Misuse in Older People

  2020cites this paper
• Preface

  2020cites this paper
• Concluding Reflections

  2020cites this paper
• Palliative Care in Dementia

  2020cites this paper
• Amyloid and Tau PET Imaging of Alzheimer Disease and Other Neurodegenerative Conditions.

  2020cites this paper
• Ultra-High Field MRI in Alzheimer’s Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo compared to Histology

  2020cites this paper
• Vascular Dementia

  2020cites this paper
• What Can Person-Centred Care in Dementia Learn from the Recovery Movement?

  2020cites this paper
• Dementia with Lewy Bodies with Pure Agraphia for Kanji (Japanese Morphograms)

  2020cites this paper
• Clinical Topics in Old Age Psychiatry

  2020cites this paper
• Index

  2020cites this paper
• Liposomes Decorated with 2-(4'-Aminophenyl)benzothiazole Effectively Inhibit Aβ1-42 Fibril Formation and Exhibit in Vitro Brain-Targeting Potential.

  2020cites this paper
• Understanding the Person with Dementia

  2020cites this paper
• Supporting Self-Management in Early Dementia

  2020cites this paper
• Reducing the Healthcare Burden of Delirium

  2020cites this paper
• Introductory Comments

  2020cites this paper
• Young-Onset Dementias

  2020cites this paper
• Biomarkers and the Diagnosis of Preclinical Alzheimer’s Disease

  2020cites this paper
• Topographical distribution of Aβ predicts progression to dementia in Aβ positive mild cognitive impairment

  2020cites this paper
• Aβ Imaging in Aging, Alzheimer’s Disease, and Other Neurodegenerative Conditions

  2020cites this paper
• The Home Assessment in Old Age Psychiatry

  2020cites this paper
• Residence Capacity

  2020cites this paper
• Usefulness of Curcumin Analogs for the Diagnosis and Treatment of Alzheimer Disease

  2019cites this paper
• [11C]PIB PET Is Associated with the Brain Biopsy Amyloid-β Load in Subjects Examined for Normal Pressure Hydrocephalus

  2019influential citation
• Neuropathological correlates of amyloid PET imaging in Down syndrome

  2019cites this paper
• Neuroimaging of Alzheimer’s disease: focus on amyloid and tau PET

  2019cites this paper
• Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease

  2019cites this paper
• Aging 1-2018 Down Syndrome , Beta-Amyloid and Neuroimaging

  2019cites this paper
• Positron emission tomography neuroimaging in neurodegenerative diseases: Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.

  2019cites this paper
• Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers

  2019cites this paper
• Mental Health Laws from All UK Jurisdictions

  2019cites this paper
• THE LIVED EXPERIENCES OF INDIVIDUALS IN EARLY-STAGE ALZHEIMER’S DISEASE: A QUALITATIVE STUDY

  2019cites this paper
• The spectrum of age-related small vessel diseases: potential overlap and interactions of amyloid and non-amyloid vasculopathies.

  2019cites this paper
• β-Amyloid PET and neuropathology in dementia with Lewy bodies

  2019cites this paper
• Correlation of Lobar Cerebral Microbleeds with Amyloid, Perfusion, and Metabolism in Alzheimer’s Disease

  2019cites this paper
• When Does Alzheimer′s Disease Really Start? The Role of Biomarkers

  2019cites this paper
• Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease.

  2019cites this paper
• Innovative Molecular Imaging for Clinical Research, Therapeutic Stratification, and Nosography in Neuroscience

  2019cites this paper
• Impact of partial volume correction on the regional correspondence between in vivo [C-11]PiB PET and postmortem measures of Aβ load

  2018cites this paper
• Association of Preclinical Alzheimer Disease With Optical Coherence Tomographic Angiography Findings

  2018cites this paper
• Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer’s disease

  2018cites this paper
• Molecular imaging in dementia: Past, present, and future

  2018cites this paper
• Florbetapir Image Analysis for Alzheimer's Disease Diagnosis

  2018cites this paper
• Down syndrome, beta-amyloid and neuroimaging.

  2018cites this paper
• USING MULTIMODAL IMAGING TO EXAMINE CLINICAL AND COGNITIVE CORRELATES OF MILD COGNITIVE IMPAIRMENT AND ALZHEIMER’S DISEASE

  2018cites this paper
• Biomarkers and the diagnosis of preclinical dementia

  2018cites this paper
• Bedeutung molekularer Bildgebung (PET) in der Diagnostik von Demenzerkrankungen

  2018cites this paper
• Molecular imaging: What is right and what is an illusion?

  2018cites this paper
• 11 CPIB-PET for the early diagnosis of Alzheimer ’ s disease dementia and other dementias in people with mild cognitive impairment ( MCI ) Review information Review type : Diagnostic test accuracy Review number : DTA 17

  2018cites this paper
• Negative 11C-PIB PET Predicts Lack of Alzheimer’s Disease Pathology in Postmortem Examination

  2018cites this paper
• Down syndrome: age-dependence of PiB binding in postmortem frontal cortex across the lifespan

  2017influential citation
• Aβ-amyloid and Tau Imaging in Dementia.

  2017cites this paper
• Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

  2017cites this paper
• Biomarkers in Neurodegenerative Diseases.

  2017cites this paper
• New PET markers for the diagnosis of dementia

  2017cites this paper
• Mémoire autobiographique et self dans la maladie d'Alzheimer : étude neuropsychologique et en neuro-imagerie

  2017cites this paper
• Tau hyperphosphorylation on T217 in cerebrospinal fluid is specifically associated to amyloid-β pathology

  2017influential citation
• The Role of Neuroimaging in the Assessment of the Cognitively Impaired Elderly.

  2017cites this paper
• Diagnosing Corticobasal Syndrome Based on the Presence of Visual Hallucinations and Imaging with Amyloid Positron Emission Tomography

  2017cites this paper
• Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.

  2017cites this paper
• Amyloid-PET burden and regional distribution in cerebral amyloid angiopathy: a systematic review and meta-analysis of biomarker performance

  2017cites this paper
• Imaging Biomarkers in Alzheimer’s Disease: A Practical Guide for Clinicians

  2017cites this paper
• Emerging concepts in sporadic cerebral amyloid angiopathy.

  2017cites this paper
• Clinical Amyloid Imaging.

  2017cites this paper
• Studying the Progression of Amyloid Pathology and Its Therapy Using Translational Longitudinal Model of Accumulation and Distribution of Amyloid Beta

  2017cites this paper
• Modelling progression and heterogeneity in Alzheimer's disease

  2017cites this paper
• Amyloid-PET in sporadic cerebral amyloid angiopathy

  2017cites this paper
• Amnestic mild cognitive impairment

  2017cites this paper
• Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update

  2017cites this paper
• Targeting protein kinases to manage or prevent Alzheimer’s disease

  2016cites this paper
• Biomarkers for the Early Detection and Progression of Alzheimer’s Disease

  2016cites this paper
• VARIANCE OF THE AMYLOID BETA PEPTIDE AS A METRIC FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE

  2016cites this paper
• Diagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer's disease

  2016cites this paper
• Florbetapir-PET to diagnose cerebral amyloid angiopathy

  2016cites this paper
• Regional correlations between [11C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort

  2016cites this paper
• Molecular Neuroimaging in Vascular Cognitive Impairment.

  2016cites this paper
• Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition

  2016cites this paper
• Imaging Amnestic Mild Cognitive Impairment: Neuroinflammation, Beta-amyloid and Glutathione

  2016cites this paper
• Tenascin-C Is Associated with Cored Amyloid-&bgr; Plaques in Alzheimer Disease and Pathology Burdened Cognitively Normal Elderly

  2016influential citation